U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C29H31N7O.CH4O3S
Molecular Weight 589.708
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Imatinib Mesylate

SMILES

CS(O)(=O)=O.CN1CCN(CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC(=CC=N4)C5=CC=CN=C5)=C(C)C=C3)CC1

InChI

InChIKey=YLMAHDNUQAMNNX-UHFFFAOYSA-N
InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
Imatinib Mesylate
HSDB   ORANGE BOOK   USAN   VANDF  
USAN  
Official Name English
IMATINIB MESYLATE [USAN]
Common Name English
IMATINIB METHANE SULFONATE
Common Name English
IMATINIB METHANESULFONATE
MI  
Common Name English
IMATINIB ACCORD
Brand Name English
IMATINIB MESILATE [MART.]
Common Name English
IMATINIB MESILATE [EP MONOGRAPH]
Common Name English
QTI571
Code English
IMATINIB MESILATE
JAN   MART.   WHO-DD  
Common Name English
Imatinib mesilate [WHO-DD]
Common Name English
IMATINIB MESYLATE [ORANGE BOOK]
Common Name English
NSC-716051
Code English
IMATINIB MESYLATE [HSDB]
Common Name English
GLIVEC
Common Name English
Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1)
Systematic Name English
IMATINIB MESYLATE [VANDF]
Common Name English
IMATINIB MESILATE [JAN]
Common Name English
4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide methanesulfonate
Common Name English
IMATINIB MEDAC
Brand Name English
GLEEVEC
Brand Name English
STI571
Code English
IMATINIB METHANESULFONATE [MI]
Common Name English
STI-571
Code English
STI 571
Code English
QTI-571
Code English
IMATINIB (AS MESILATE)
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 209005
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB ACCORD (AUTHORIZED: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB MEDAC (AUTHORIZED: HYPEREOSINOPHILIC SYNDROME)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB ACTAVIS (AUTHORIZED: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS GLIVEC (AUTHORIZED: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS GLIVEC (AUTHORIZED: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
FDA ORPHAN DRUG 209205
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
FDA ORPHAN DRUG 149201
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
NCI_THESAURUS C155700
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB MEDAC (AUTHORIZED: MYELODYPLASTIC-MYELOPROLIFERATIVE DISEASES)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS GLIVEC (AUTHORIZED: HYPEREOSINOPHILIC SYNDROME)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS GLIVEC (AUTHORIZED: MYELODYPLASTIC-MYELOPROLIFERATIVE DISEASES)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB ACCORD (AUTHORIZED: MYELODYPLASTIC-MYELOPROLIFERATIVE DISEASES)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB MEDAC (AUTHORIZED: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
FDA ORPHAN DRUG 428914
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB ACCORD (AUTHORIZED: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
FDA ORPHAN DRUG 209105
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB ACCORD (AUTHORIZED:HYPEREOSINOPHILIC SYNDROME)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EU-Orphan Drug EU/3/01/021
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB TEVA (AUTHORIZED:
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
FDA ORPHAN DRUG 208805
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
FDA ORPHAN DRUG 741420
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB MEDAC (AUTHORIZED: LEUKEMIA, MYELOMONOCYTIC, CHRONIC)
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
Code System Code Type Description
HSDB
7142
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
RXCUI
284924
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY RxNorm
EPA CompTox
DTXSID9040502
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
MERCK INDEX
m6213
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY Merck Index
EVMPD
SUB12517MIG
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
DRUG BANK
DBSALT000098
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
PUBCHEM
123596
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
DAILYMED
8A1O1M485B
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
SMS_ID
100000091825
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
USAN
MM-81
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
ChEMBL
CHEMBL941
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
NCI_THESAURUS
C1687
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
CHEBI
45783
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
NSC
716051
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
FDA UNII
8A1O1M485B
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
CHEBI
31690
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
CAS
220127-57-1
Created by admin on Fri Dec 15 15:49:05 UTC 2023 , Edited by admin on Fri Dec 15 15:49:05 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of IMATINIB
SUBSTANCE RECORD
Structure of Imatinib Mesylate
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966